Xcout Intel
Auron Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Auron Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Auron Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Auron Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Auron Therapeutics, Inc.
Auron Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts. The company focuses on targeting cell states to deliver next-generation targeted cancer therapies.
Auron Therapeutics, Inc. at a glance
Auron Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $98.5M across the 5 funding rounds on record. Its most recent funding round raised $7.1M in August 2026. Xcout tracks 26 named people at Auron Therapeutics, Inc., including Katharine Yen (President).
Auron Therapeutics, Inc. leadership
- Katharine YenPresident
- Glenn GoddardChief Financial Officer
- Thomas Graeber, Ph.D.Chief Data Officer
- Katharine Yen, Ph.D.Founder & CEO
- Eytan Stein, M.D.Founder
- Matthew Vander Heiden, M.D., Ph.D.Founder
20 more named people on record for Auron Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Auron Therapeutics, Inc. funding rounds
At least $98.5M raised across the 5 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7.1M | — | |
| Series B | $27.3M | 9 named | |
| Series B | $48M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Auron Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Auron Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Abcuro, Inc. is a biotechnology company headquartered in Newton, Massachusetts, focused on developing advanced immunotherapies to treat autoimmune diseases and cancer.
Similar biotechnology company
Accent Therapeutics, Inc. is a biopharmaceutical company headquartered in Lexington, Massachusetts, focused on translating scientific research into novel therapeutics. The company conducts clinical trials, such as Phase 1/2 studies, targeting oncology and other serious diseases.
Biotech
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Similar biotechnology company
Apeiron Therapeutics is a clinical-stage biopharmaceutical and precision oncology company focused on developing biomarker-driven therapeutics for cancer.
Similar biotechnology company
Aurora Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts. The firm focuses on advanced biomedical research and therapeutic development within the life sciences sector.
Biotech
Orum Therapeutics is a biotechnology research company specializing in the development of targeted protein degraders for precision oncology using its TPD² approach. The company is headquartered in Daejeon, South Korea, with additional offices in Boston, Massachusetts.
Similar biotechnology company
Allorion Therapeutics is a US-based organization headquartered in Natick, Massachusetts, with additional operations in China, specializing in the discovery and creation of small molecule drugs using a science- and data-driven R&D strategy.
Similar biotechnology company
PIC Therapeutics, Inc. is a biopharmaceutical company headquartered in Natick, Massachusetts, dedicated to developing life-changing medicines for patients with cancer. The company focuses on oncology research and therapeutic product development.
Biotech
Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways. The company's primary drug candidate, ATRN-119, is an oral ATR inhibitor currently undergoing Phase 1/2a clinical trials for patients with advanced solid tumors. Beyond this lead compound, Aprea's developmental pipeline includes ATRN-Backup, which is also an ATR inhibitor; ATRN-W1051, being explored for its anti-tumor effects; and ATRN-DDRi. Aprea Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Biotech
Kernal Biologics is an onco-selective mRNA therapeutics company located in Cambridge, Massachusetts, that creates mRNA therapies designed to instruct specific cells on how to make proteins.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Similar biotechnology company
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Auron Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Auron Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →